Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""van Oort, I. M."" wg kryterium: Autor


Tytuł :
The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population.
Autorzy :
Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands. .; Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, the Netherlands. .
Kuppen MCP; Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, the Netherlands.
van den Eertwegh AJM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
de Wit R; Department of Medical Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, the Netherlands.
Bergman AM; Division of Internal Medicine (MOD) and Oncogenomics, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
van Moorselaar RJA; Department of Urology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
Coenen JLLM; Department of Internal Medicine, Isala Klinieken, Zwolle, the Netherlands.
van den Bergh ACM; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands.
Somford DM; Department of Urology, Canisius Wilhemina Hospital, Nijmegen, the Netherlands.
Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.
Aben KKH; Department for Health Evidence, Radboud University Medical Center, The Netherlands and Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Uyl-de Groot CA; Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, the Netherlands.
Pokaż więcej
Źródło :
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2021 Mar 21. Date of Electronic Publication: 2021 Mar 21.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration-resistant prostate cancer undergoing first-line abiraterone acetate and prednisone treatment.
Autorzy :
Boerrigter E; Department of Pharmacy, Radboud university medical center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
Benoist GE; Department of Pharmacy, Radboud university medical center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboud university medical center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Verhaegh GW; Department of Urology, Radboud university medical center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
van Hooij O; Department of Urology, Radboud university medical center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Groen L; Department of Urology, Radboud university medical center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Smit F; MDxHealth, Nijmegen, The Netherlands.
Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, The Netherlands.
de Mol P; Department of Medical Oncology, Gelderse Vallei Hospital, Ede, The Netherlands.
Smilde TJ; Department of Medical Oncology, Jeroen Bosch Hospital, Hertogenbosch, The Netherlands.
Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Mehra N; Deparment of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands.
Schalken JA; Department of Urology, Radboud university medical center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
van Erp NP; Department of Pharmacy, Radboud university medical center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
Molecular oncology [Mol Oncol] 2021 Mar 02. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Histopathological re-evaluations of biopsies in prostate cancer: a nationwide observational study.
Autorzy :
van Santvoort BWH; Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
van Leenders GJLH; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Kiemeney LA; Department for Health Evidence, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.; Department of Urology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
van Oort IM; Department of Urology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
Wieringa SE; Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Jansen H; Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Vernooij RWM; Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Hulsbergen-van de Kaa CA; Laboratory of Pathology East-Netherlands, Hengelo, the Netherlands.
Aben KKH; Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.; Department for Health Evidence, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
Scandinavian journal of urology [Scand J Urol] 2020 Dec; Vol. 54 (6), pp. 463-469. Date of Electronic Publication: 2020 Aug 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study.
Autorzy :
Vernooij RWM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
Cremers RGHM; Department of Urology, Deventer Hospital, Deventer, the Netherlands.
Jansen H; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
Kiemeney LA; Radboud Institute for Health Sciences, Department of Urology, Radboud university medical center, Nijmegen, the Netherlands; Radboud Institute for Health Sciences, Department for Health Evidence, Radboud university medical center, Nijmegen, the Netherlands.
van Andel G; Department of Urology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
Wijsman BP; Department of Urology, Elisabeth-TweeSteden hospital, Tilburg, the Netherlands.
Busstra MB; Department of Urology, Erasmus University Medical Center, Rotterdam, the Netherlands.
van Moorselaar RJA; Department of Urology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Wijnen EM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
Pos FJ; Department of Radiotherapy, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands.
Hulshof MCCM; Department of Radiotherapy, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Hamberg P; Department of Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
van den Berkmortel F; Department of Oncology, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.
Hulsbergen-van de Kaa CA; Department of Pathology, Laboratory for Pathology East Netherlands, Hengelo, the Netherlands.
van Leenders GJLH; Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Fütterer JJ; Department of Radiology, Radboud University Medical Center, Nijmegen, the Netherlands.
van Oort IM; Radboud Institute for Health Sciences, Department of Urology, Radboud university medical center, Nijmegen, the Netherlands.
Aben KKH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands; Radboud Institute for Health Sciences, Department for Health Evidence, Radboud university medical center, Nijmegen, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Urologic oncology [Urol Oncol] 2020 Sep; Vol. 38 (9), pp. 735.e17-735.e25. Date of Electronic Publication: 2020 Jul 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Ga-PSMA-PET/CT and Diffusion MRI Targeting for Cone-Beam CT-Guided Bone Biopsies of Castration-Resistant Prostate Cancer Patients.
Autorzy :
van Steenbergen TRF; Department of Radiology and Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. .
Smits M; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Scheenen TWJ; Department of Radiology and Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Rovers MM; Department of Operating Rooms, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Fütterer JJ; Department of Radiology and Nuclear Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
Cardiovascular and interventional radiology [Cardiovasc Intervent Radiol] 2020 Jan; Vol. 43 (1), pp. 147-154. Date of Electronic Publication: 2019 Aug 23.
Typ publikacji :
Journal Article
MeSH Terms :
Oligopeptides*
Bone Neoplasms/*pathology
Cone-Beam Computed Tomography/*methods
Diffusion Magnetic Resonance Imaging/*methods
Edetic Acid/*analogs & derivatives
Positron Emission Tomography Computed Tomography/*methods
Prostatic Neoplasms, Castration-Resistant/*pathology
Aged ; Bone Neoplasms/diagnostic imaging ; Bone Neoplasms/secondary ; Bone and Bones/diagnostic imaging ; Bone and Bones/pathology ; Humans ; Image-Guided Biopsy ; Male ; Middle Aged ; Pilot Projects ; Prospective Studies ; Radiography, Interventional/methods ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
68Ga-PSMA-PET/CT and Diffusion MRI Targeting for Cone-Beam CT-Guided Bone Biopsies of Castration-Resistant Prostate Cancer Patients
Autorzy :
van Steenbergen, T. R. F.
Smits, M.
Scheenen, T. W. J.
van Oort, I. M.
Nagarajah, J.
Rovers, M. M.
Mehra, N.
Fütterer, J. J.
Pokaż więcej
Temat :
Technical Note
Castration resistant prostate cancer
Molecular analysis
Bone biopsy
PSMA-PET/CT
Diffusion MRI
Cone-beam CT
Źródło :
Cardiovascular and Interventional Radiology
Tytuł :
Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.
Autorzy :
Hendriks RJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Schalken JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2017 Mar; Vol. 20 (1), pp. 12-19. Date of Electronic Publication: 2016 Dec 06.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Biomarkers, Tumor*/blood
Biomarkers, Tumor*/urine
Prostatic Neoplasms/*diagnosis
Antigens, Neoplasm/blood ; Antigens, Neoplasm/urine ; Biopsy ; Clinical Decision-Making ; Disease Management ; Humans ; Liquid Biopsy ; Male ; Neoplasm Grading ; Neoplasm Staging ; Prognosis ; Prostatectomy/methods ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/therapy ; Prostatic Neoplasms/urine ; Risk Assessment
Czasopismo naukowe
Tytuł :
The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Autorzy :
Somford DM; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: .
Hamoen EH
Fütterer JJ
van Basten JP
Hulsbergen-van de Kaa CA
Vreuls W
van Oort IM
Vergunst H
Kiemeney LA
Barentsz JO
Witjes JA
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2013 Nov; Vol. 190 (5), pp. 1728-34. Date of Electronic Publication: 2013 May 13.
Typ publikacji :
Journal Article
MeSH Terms :
Magnetic Resonance Imaging/*methods
Prostatic Neoplasms/*pathology
Humans ; Male ; Middle Aged ; Neoplasm Invasiveness ; Predictive Value of Tests ; Prostatectomy ; Prostatic Neoplasms/surgery ; Rectum ; Risk Assessment
Czasopismo naukowe
Tytuł :
Quality of life after prostate cancer treatments in patients comparable at baseline.
Autorzy :
van Tol-Geerdink JJ; Department of Radiation Oncology, Radboud University Medical Centre, PO Box 9101, Nijmegen, The Netherlands. />Leer JW
van Oort IM
van Lin EJ
Weijerman PC
Vergunst H
Witjes JA
Stalmeier PF
Pokaż więcej
Źródło :
British journal of cancer [Br J Cancer] 2013 May 14; Vol. 108 (9), pp. 1784-9. Date of Electronic Publication: 2013 Apr 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Quality of Life*
Brachytherapy/*adverse effects
Prostatectomy/*adverse effects
Prostatic Neoplasms/*radiotherapy
Prostatic Neoplasms/*surgery
Aged ; Brachytherapy/methods ; Erectile Dysfunction ; Health Status ; Humans ; Laparoscopy ; Male ; Middle Aged ; Prostatectomy/methods ; Surveys and Questionnaires ; Treatment Outcome ; Urinary Incontinence
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies